BECONASE AQ
LOE ApproachingNDANASALSPRAY, METERED
Approved
Jul 1987
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Data completeness
4/8 — Partial
BECONASE AQ by GSK is clinical pharmacology mechanism of action following topical administration, beclomethasone dipropionate produces anti-inflammatory and vasoconstrictor effects. Approved for recurrence of nasal polyps following surgical removal. First approved in 1987.
Drug data last refreshed 43m ago · AI intelligence enriched 2w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
BECONASE AQ is a metered nasal spray containing beclomethasone dipropionate, a topical corticosteroid approved for intranasal use. It works as a pro-drug that is hydrolyzed to its active metabolite (B-17-MP), which exerts anti-inflammatory and vasoconstrictor effects on nasal mucosa. The drug is indicated for recurrence of nasal polyps following surgical removal.
$0.001BPart D
LOE ApproachingProduct is in late-stage lifecycle with minimal Part D spending (~$1M in 2023 across 3,065 claims), indicating a niche indication with limited commercial growth potential and likely small team size.
Mechanism of Action
CLINICAL PHARMACOLOGY Mechanism of Action Following topical administration, beclomethasone dipropionate produces anti-inflammatory and vasoconstrictor effects. The mechanisms responsible for the anti-inflammatory action of beclomethasone dipropionate are unknown. Corticosteroids have been shown to…
Worked on BECONASE AQ at GSK? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.